Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
61.7M
-
Number of holders
-
95
-
Total 13F shares, excl. options
-
50.4M
-
Shares change
-
-938K
-
Total reported value, excl. options
-
$74.6M
-
Value change
-
+$1.5M
-
Put/Call ratio
-
1.43
-
Number of buys
-
31
-
Number of sells
-
-68
-
Price
-
$1.48
Significant Holders of PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX) as of Q3 2025
125 filings reported holding PLRX - PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share as of Q3 2025.
PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX) has 95 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50.4M shares
of 61.7M outstanding shares and own 81.64% of the company stock.
Largest 10 shareholders include TANG CAPITAL MANAGEMENT LLC (6M shares), Woodline Partners LP (4.5M shares), Point72 Asset Management, L.P. (4.34M shares), MORGAN STANLEY (3.51M shares), Blue Owl Capital Holdings LP (2.97M shares), VANGUARD GROUP INC (2.78M shares), ACADIAN ASSET MANAGEMENT LLC (2.37M shares), CITADEL ADVISORS LLC (2.34M shares), JPMORGAN CHASE & CO (2.13M shares), and Redmile Group, LLC (1.59M shares).
This table shows the top 95 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.